Tag: Clots
Idarucizumab Deemed Effective for Dabigatran Reversal
Findings among patients with serious bleeding or who require an urgent procedure
No Clinical Benefit Found for Occult Cancer CT Screening in VTE
Prevalence of occult cancer low among patients with first unprovoked venous thromboembolism
Forgoing Bridging Anticoagulation Noninferior in A-Fib
Findings in patients with atrial fibrillation undergoing elective operation, invasive procedure
Use of Novel Oral Anticoagulants Increasing in A-Fib
Findings in patients with atrial fibrillation hospitalized for stroke or transient ischemic attack
Younger Adults Receiving Excess Anticoagulant Dosing in PCI
Excess dosing for 42.7 percent during PCI; trend toward link between excess dosing, bleeding
Venous Thromboembolism Rates Low After Colorectal Surgery
No decrease in rates despite increased use of perioperative, in-hospital VTE chemoprophylaxis
Anticoagulation Appears Safe for Patients With Brain Mets
Treatment does not cause significant increase in incidence of intracranial hemorrhage
Most ER Patients With Low-Risk PE Eligible for Outpatient Tx
Increased frequency of 30-day adverse events for patients with contraindications to outpatient tx
Weight-Based Enoxoparin Dosing Best for Obese After C-Section
Weight-based dosing more effective than BMI-based dosing for venous thromboembolism prophylaxis
Higher Risk of VTE With Newer Forms of Oral Contraceptives
Includes brands such as Yaz, Yasmin, Desogen; risk to any one user remains very low
